Market Intelligence & Commercial Execution Projects
Healthtech & Biotech Focus
Global Experts in Network
Why great products fail commercially
European healthtech
of surveyed European healthtech ventures have not reached a sufficient level of market intelligence.
Source: Peak Spirit & Health-Trends, Venture Market Access Readiness in HealthTech (2025), published at Springer
This lack of focus on market understanding is the number one reason great products fail commercially, and the reason investors now treat a validated commercial strategy as a funding condition. In healthtech, commercialization fails for five concrete reasons.
Where commercialization breaks
01
Complex stakeholder landscapes
02
Fragmented reimbursement pathways
03
Challenging customer access
04
No business case for the buyer
05
Pilots that never convert
Peak Spirit solves these challenges. We take you from understanding what the market needs, to professional B2B marketing and value models, to running the full piloting and sales process, until you have signed customers and are ready to scale.
300+ projects. Real results.
Commercial traction across Europe and North America, sorted by outcome.
6-figure sales revenue enabled through long-term collaboration.
“In over four years of collaboration, Peak Spirit has never failed to deliver tangible outcomes.”
Trusted by
Selected Clients & Partners
Team
We Are Peak Spirit.
A Zurich-based team with 370+ healthtech and biotech experts in our global network.
Meet the full team
Siro Gottardi→
CEO & Partner
Niklas Struller→
Consultant, Market Entry & Sales Expert
Ilya Chuev→
Consultant, Market Entry Strategist
Dr. Simon Nebel→
Partner, Financing & BD Expert
Sophie Hasslauer→
Working Student
Daniel Pajer→
Partner, Finance & Accounting Expert
Valentin Splett→
Partner, Serial Entrepreneur
Dr. Thomas Meier→
Partner, Serial Life-Science Entrepreneur
Next step
Every successful market entry starts with the right intelligence. Let’s build yours.
Let’s talk.
Part of Viopas Venture Consulting Group